CD200 is a new marker that was found to be up-regulated in chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) when compared with normal B cells by flow cytometry immunophenotyping [11]. This evidence concerns the gene CD200 and B-cell chronic lymphocytic leukemia.